Plasma exchange therapy for steroid-unresponsive multiple sclerosis relapses. Clinical experience with 16 patients;Plasmaaustausch bei steroidresistenten multiple-sklerose-schüben. Klinische erfahrungen an 16 patienten

Nervenarzt

Volumn 77, Issue 4, 2006, Pages 430-438

  Schilling, S ^a   Linker, R ^a,b   Konig F ^b   Koziolek, M ^b   Bahr M ^b   Muller G ^b   Paulus, W ^b   Gartner J ^b   Bruck W ^b   Chan, A ^a,b   Gold, R ^a  

^a Gemeinnutzige Hertie Stiftung   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Corticosteroids; Escalating immunotherapy; Multiple sclerosis relapse; Plasma exchange

Indexed keywords

BETA1A INTERFERON; CORTICOSTEROID; GLATIRAMER; HEPARIN; MITOXANTRONE;

ADULT; CHILD; CLINICAL ARTICLE; FEMALE; HUMAN; IMMUNOTHERAPY; MALE; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NEURITIS; PLASMAPHERESIS; RELAPSE; REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME;

ACTIVITIES OF DAILY LIVING; ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS; BRAIN; CHILD; COMBINED MODALITY THERAPY; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MAGNETIC RESONANCE IMAGING; MALE; METHYLPREDNISOLONE; MIDDLE AGED; MULTIPLE SCLEROSIS; NEUROLOGIC EXAMINATION; NEUROMYELITIS OPTICA; PLASMA EXCHANGE; RECURRENCE; RETROSPECTIVE STUDIES;

EID: 33645461438     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00115-005-2019-1     Document Type: Review

References (11)

1. Milligan NM, Newcombe R, Compston DA (1987) A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. clinical effects. J Neurol Neurosurg Psychiatry 50:511-516
2. Rieckmann P, Toyka KV, Bassetti C et al. (2004) Escalating immunotherapy of multiple sclerosis-new aspects and practical application. J Neurol 251:1329-1339
3. Weinshenker BG, O'Brien PC, Petterson TM et al. (1999) A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol 46:878-886
4. Ruprecht K, Klinker E, Dintelmann T et al. (2004) Plasma exchange for severe optic neuritis: treatment of 10 patients. Neurology 63:1081-1083
5. Keegan M, Konig F, McClelland R et al. (2005) Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange. Lancet 366:579-582
6. Lucchinetti C, Bruck W, Parisi J et al. (2000) Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47:707-717
7. Keegan M, Pineda AA, McClelland RL et al. (2002) Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology 58:143-146
8. Lucchinetti CF, Mandler RN, McGavern D et al. (2002) A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 125:1450-1461
9. Stangel M, Hartung HP, Marx P et al. (1998) Intravenous immunoglobulin treatment of neurological autoimmune diseases. J Neurol Sci 153:203-214
10. Bruck W, Neubert K, Berger T et al. (2001) Clinical, radiological, immunological and pathological findings in inflammatory CNS demyelination- possible markers for an antibody-mediated process. Mult Scler 7:173-177
11. Mann H (2003) Apherese-Standard der Deutschen Arbeitsgemeinschaft für Klinische Nephrologie e.V.